| Dioscin | Ki | 1030.0 [1], 1430.0 [2], 4550.0 [3], 8290.0 [4] |
| Silymarin | IC50 | 2700.0 [1], 4265.8 [2] |
| Silymarin | Ki | 3270.0 [1] |
| Calcium | IC50 | 3388.44 [1] |
| Calcium | Ki | 2580.0 [1] |
| Sodium | IC50 | 1905.46 [1] |
| Sodium | Ki | 1480.0 [1] |
| Bilirubin | IC50 | 3388.44 [1] |
| Bilirubin | Ki | 2630.0 [1] |
| Vincristine | IC50 | 11000.0 [1], 36780.0 [2] |
| Rifampicin | IC50 | 1500.0 [1] |
| Rifampicin | Ki | 5000.0 [1] |
| Arachidonic acid | IC50 | 1071.52 [1] |
| Arachidonic acid | Ki | 820.0 [1] |
| Genistein | IC50 | 3890.45 [1] |
| Genistein | Ki | 2960.0 [1] |
| Losartan | IC50 | 1148.15 [1] |
| Losartan | Ki | 890.0 [1] |
| beta-Carotene | IC50 | 2951.21 [1] |
| beta-Carotene | Ki | 2260.0 [1] |
| Tannic acid | IC50 | 4168.69 [1] |
| Tannic acid | Ki | 3230.0 [1] |
| Telmisartan | IC50 | 1258.93 [1] |
| Telmisartan | Ki | 960.0 [1] |
| Enoxolone | IC50 | 549.54 [1] |
| Enoxolone | Ki | 420.0 [1] |
| Gossypol | IC50 | 4570.88 [1] |
| Gossypol | Ki | 3470.0 [1] |
| Hydroxyzine pamoate | IC50 | 1230.27 [1] |
| Hydroxyzine pamoate | Ki | 940.0 [1] |
| Olmesartan medoxomil | IC50 | 977.24 [1] |
| Olmesartan medoxomil | Ki | 750.0 [1] |
| Mometasone furoate | IC50 | 1148.15 [1] |
| Mometasone furoate | Ki | 870.0 [1] |
| Nonoxynol-9 | IC50 | 3715.35 [1] |
| Nonoxynol-9 | Ki | 2870.0 [1] |
| Lasalocid sodium | IC50 | 776.25 [1] |
| Lasalocid sodium | Ki | 590.0 [1] |
| Candesartan cilexetil | IC50 | 2454.71 [1] |
| Candesartan cilexetil | Ki | 1900.0 [1] |
| Dicloxacillin sodium monohydrate | IC50 | 1995.26 [1] |
| Dicloxacillin sodium monohydrate | Ki | 1550.0 [1] |
| Erythromycin ethylsuccinate | IC50 | 2089.3 [1] |
| Erythromycin ethylsuccinate | Ki | 1610.0 [1] |
| Retinyl acetate | IC50 | 5011.87 [1] |
| Retinyl acetate | Ki | 3890.0 [1] |
| (-)-Epicatechin gallate | IC50 | 4466.84 [1] |
| (-)-Epicatechin gallate | Ki | 3460.0 [1] |
| Abietic acid | IC50 | 5248.07 [1] |
| Abietic acid | Ki | 4080.0 [1] |
| Erythromycin estolate | IC50 | 3090.3 [1] |
| Erythromycin estolate | Ki | 2350.0 [1] |
| Sarsasapogenin | IC50 | 104.71 [1] |
| Sarsasapogenin | Ki | 80.0 [1] |
| Hederagenin | IC50 | 891.25 [1] |
| Hederagenin | Ki | 680.0 [1] |
| Aurin | IC50 | 4073.8 [1] |
| Aurin | Ki | 3150.0 [1] |
| Lobaric acid | IC50 | 1621.81 [1] |
| Lobaric acid | Ki | 1250.0 [1] |
| Methyl cholate | IC50 | 3715.35 [1] |
| Methyl cholate | Ki | 2890.0 [1] |
| Norstictic acid | IC50 | 549.54 [1] |
| Norstictic acid | Ki | 420.0 [1] |
| Theasinensin B | IC50 | 8511.38 [1] |
| Theasinensin B | Ki | 6500.0 [1] |
| Scandenin | IC50 | 741.31 [1] |
| Scandenin | Ki | 560.0 [1] |
| Anthothecol | IC50 | 3467.37 [1] |
| Anthothecol | Ki | 2640.0 [1] |
| (2S,3S,4S,5R,6R)-6-[[(3S,4S,6Ar,6bR,8R,8aR,9R,10R,14aR,14bS)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-6a,6b,11,11,14b-pentamethyl-10-[(E)-2-methylbut-2-enoyl]oxy-2,3,4,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydro-1H-picen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid | IC50 | 3388.44 [1] |
| (2S,3S,4S,5R,6R)-6-[[(3S,4S,6Ar,6bR,8R,8aR,9R,10R,14aR,14bS)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-6a,6b,11,11,14b-pentamethyl-10-[(E)-2-methylbut-2-enoyl]oxy-2,3,4,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydro-1H-picen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid | Ki | 2610.0 [1] |
| Acetyl isogambogic acid | IC50 | 5370.32 [1] |
| Acetyl isogambogic acid | Ki | 4170.0 [1] |
| Methyl (2S,3R,4R,5S)-4-[(1S,3aS,5R,6R,7R,7aR)-6-formyloxy-1-(furan-3-yl)-3a-hydroxy-7-[(2R,3R)-2-hydroxy-3-methylpentanoyl]oxy-7a-methyl-4-methylidene-3-oxo-2,5,6,7-tetrahydro-1H-inden-5-yl]-5-acetyloxy-2-(acetyloxymethyl)-2,4-dimethyl-7-oxooxepane-3-carboxylate | IC50 | 3388.44 [1] |
| Methyl (2S,3R,4R,5S)-4-[(1S,3aS,5R,6R,7R,7aR)-6-formyloxy-1-(furan-3-yl)-3a-hydroxy-7-[(2R,3R)-2-hydroxy-3-methylpentanoyl]oxy-7a-methyl-4-methylidene-3-oxo-2,5,6,7-tetrahydro-1H-inden-5-yl]-5-acetyloxy-2-(acetyloxymethyl)-2,4-dimethyl-7-oxooxepane-3-carboxylate | Ki | 2630.0 [1] |
| Methyl 6-acetoxyangolensate | IC50 | 3801.89 [1] |
| Methyl 6-acetoxyangolensate | Ki | 2920.0 [1] |
| Leoidin | IC50 | 2398.83 [1] |
| Leoidin | Ki | 1840.0 [1] |
| Gangaleoidin | IC50 | 2630.27 [1] |
| Gangaleoidin | Ki | 2020.0 [1] |
| Bussein | IC50 | 691.83 [1] |
| Bussein | Ki | 530.0 [1] |
| Utilin | IC50 | 776.25 [1] |
| Utilin | Ki | 600.0 [1] |
| Chukrasin methyl ether | IC50 | 724.44 [1] |
| Chukrasin methyl ether | Ki | 560.0 [1] |
| Dimethyl gambogate | IC50 | 5128.61 [1] |
| Dimethyl gambogate | Ki | 3940.0 [1] |
| Dihydrogambogic acid | IC50 | 2884.03 [1] |
| Dihydrogambogic acid | Ki | 2240.0 [1] |
| Garcinolic acid | IC50 | 2238.72 [1] |
| Garcinolic acid | Ki | 1730.0 [1] |
| [(2R,3R,4S,5R)-3-[(2R,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bR)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | IC50 | 5248.07 [1] |
| [(2R,3R,4S,5R)-3-[(2R,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-3,5-Dihydroxy-4-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bR)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | Ki | 4020.0 [1] |
| Decahydrogambogic acid | IC50 | 2290.87 [1] |
| Decahydrogambogic acid | Ki | 1770.0 [1] |
| [(1R,2R,4S,7R,8R,11R,12S,13S,15R,17S,19R)-13-Acetyloxy-7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecan-15-yl] acetate | IC50 | 2951.21 [1] |
| [(1R,2R,4S,7R,8R,11R,12S,13S,15R,17S,19R)-13-Acetyloxy-7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecan-15-yl] acetate | Ki | 2270.0 [1] |